Published in JAMA on May 15, 2013
Payment for oncolytics in the United States: a history of buy and bill and proposals for reform. J Oncol Pract (2014) 2.03
The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities. Health Aff (Millwood) (2014) 1.10
Drug discount program. JAMA (2013) 0.97
Drug discount program. JAMA (2013) 0.95
The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012. Health Aff (Millwood) (2014) 0.77
Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist. Am Soc Clin Oncol Educ Book (2015) 0.75
Pharmaceutical pricing, cost containment and new treatments for rare diseases in children. Orphanet J Rare Dis (2014) 0.75
Drug discount program--reply. JAMA (2013) 0.75
Value-Based Physician Payment in Oncology: Public and Private Insurer Initiatives. Milbank Q (2017) 0.75
Improving outpatient oncology practice: several steps into a long journey. J Oncol Pract (2014) 0.75
Diffusion of Bevacizumab Across Oncology Practices: An Observational Study. Med Care (2018) 0.75
How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Aff (Millwood) (2010) 3.24
Strategic integration of hospitals and physicians. J Health Econ (2005) 2.44
Finance. New Medicare cuts will force hospitals to plug major revenue leak. Hosp Health Netw (2010) 1.66
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63
Variations in morbidity after radical prostatectomy. N Engl J Med (2002) 7.26
Care patterns in Medicare and their implications for pay for performance. N Engl J Med (2007) 6.74
Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.83
Physician visits prior to treatment for clinically localized prostate cancer. Arch Intern Med (2010) 4.11
The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med (2003) 4.01
NCCN Task Force Report: Oral chemotherapy. J Natl Compr Canc Netw (2008) 3.82
Primary care physicians' links to other physicians through Medicare patients: the scope of care coordination. Ann Intern Med (2009) 3.59
Delivery of preventive services to older adults by primary care physicians. JAMA (2005) 3.53
Rapid-learning system for cancer care. J Clin Oncol (2010) 3.13
A paradigm shift in U.S. Breast reconstruction: increasing implant rates. Plast Reconstr Surg (2013) 3.00
State expenditures for tobacco-control programs and the tobacco settlement. N Engl J Med (2002) 2.81
Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg (2002) 2.71
How Medicare could use comparative effectiveness research in deciding on new coverage and reimbursement. Health Aff (Millwood) (2010) 2.68
Federal initiatives to support rapid learning about new technologies. Health Aff (Millwood) (2007) 2.36
Survivorship care plans in research and practice. CA Cancer J Clin (2012) 2.31
Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists. J Clin Oncol (2013) 2.20
Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg (2012) 2.08
The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg (2004) 1.97
Cancer's next frontier: addressing high and increasing costs. JAMA (2010) 1.93
Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol (2002) 1.93
Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol (2003) 1.73
Lung cancer in US women: a contemporary epidemic. JAMA (2004) 1.70
Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population. Urology (2005) 1.69
The epidemiology and costs of chronic critical illness. Crit Care Clin (2002) 1.63
Prevalence and risk factors for symptomatic thromboembolic events after shoulder arthroplasty. Clin Orthop Relat Res (2006) 1.55
Validation of a model of lung cancer risk prediction among smokers. J Natl Cancer Inst (2006) 1.55
Raising the bar for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 1.52
Clinical prediction rule for atrial fibrillation after coronary artery bypass grafting. J Am Coll Cardiol (2004) 1.46
Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer. Cancer (2010) 1.40
Untreated patients in "CT screening for lung cancer: update 2007". Oncologist (2008) 1.38
Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources. Med Care (2002) 1.36
Translating genomics in cancer care. J Natl Compr Canc Netw (2013) 1.35
Adherence to surveillance among patients with superficial bladder cancer. J Natl Cancer Inst (2003) 1.31
Geographic access and the use of screening mammography. Med Care (2010) 1.30
Fragmentation of care for frequently hospitalized urban residents. Med Care (2006) 1.29
Do the data support the comorbidity hypothesis for the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial results? J Clin Oncol (2011) 1.24
Cost sharing for health care--whose skin? Which game? N Engl J Med (2008) 1.12
Pem and the cost of multicycle maintenance. J Thorac Oncol (2010) 1.10
Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics. Med Care (2007) 1.09
Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer. N Engl J Med (2014) 1.07
Overuse of health care services: when less is more … more or less. JAMA Intern Med (2013) 1.06
Using practice guidelines to assess cancer care quality. J Clin Oncol (2005) 1.06
Overdiagnosis in lung cancer: different perspectives, definitions, implications. Thorax (2008) 1.05
Postmenopausal hormone therapy and breast cancer: an uncertain trade-off. JAMA (2010) 1.05
A decade of mortality reductions in major oncologic surgery: the impact of centralization and quality improvement. Med Care (2010) 1.04
Radiation therapy facilities in the United States. Int J Radiat Oncol Biol Phys (2006) 1.01
Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations. J Clin Oncol (2003) 1.00
The influence of sociodemographic factors and hospital characteristics on the method of breast reconstruction, including microsurgery: a U.S. population-based study. Plast Reconstr Surg (2012) 1.00
A prognostic model for 6-month mortality in elderly survivors of critical illness. Chest (2013) 1.00
Computed tomography screening for lung cancer. Ann Intern Med (2013) 0.96
Risk charts: putting cancer in context. J Natl Cancer Inst (2002) 0.92
Outcome-blinded peer review. Arch Intern Med (2011) 0.92
Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2006) 0.89
Changes in the availability of screening mammography, 2000-2010. Cancer (2013) 0.89
The association between hospital volume and total shoulder arthroplasty outcomes. Clin Orthop Relat Res (2005) 0.87
Estimating individual risk for lung cancer. Semin Respir Crit Care Med (2011) 0.87
Infused chemotherapy use in the elderly after patent expiration. Am J Manag Care (2012) 0.85
Validity of same-side reoperation after total hip and knee arthroplasty using administrative databases. J Knee Surg (2009) 0.84
Reduced lung-cancer mortality with CT screening. N Engl J Med (2011) 0.84
Quality wrapped in volume inside a hospital. Ann Intern Med (2009) 0.84
Bilateral Mastectomy versus Breast-Conserving Surgery for Early-Stage Breast Cancer: The Role of Breast Reconstruction. Plast Reconstr Surg (2015) 0.82
Association between quality of care and the sociodemographic composition of physicians' patient panels: a repeat cross-sectional analysis. J Gen Intern Med (2011) 0.81
Commentary: Medicare's 2006 Oncology Demonstration Project: Lost in Translation? J Oncol Pract (2010) 0.80
Consider saying yes. Crit Care Med (2003) 0.79
Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis. J Natl Cancer Inst (2008) 0.78
Provider Differences in Use of Implanted Ports in Older Adults With Cancer. Med Care (2015) 0.76
Cost-effectiveness analysis of an established, effective procedure. Arch Intern Med (2009) 0.76
Multiplicities in the assessment of multiple vitamins: is it too soon to tell men that vitamins prevent cancer? JAMA (2012) 0.75
Response. Chest (2013) 0.75
The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial. Ann Surg (2016) 0.75
Do surgical quality gaps cause healthcare disparities? Med Care (2008) 0.75
Survival in women after diagnosis of lung cancer. JAMA (2007) 0.75
Re: All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst (2002) 0.75
Adjuvant anthracyclines and taxanes: quantifying the costs of therapeutic advances in breast cancer. Onkologie (2009) 0.75
CT screening for lung cancer. N Engl J Med (2007) 0.75
Response to "CT screening for lung cancer: update 2007". Oncologist (2008) 0.75
Infused chemotherapy use in the elderly after patent expiration. J Oncol Pract (2012) 0.75
Race, Ethnicity, Health Insurance, and Mortality in Older Survivors of Critical Illness. Crit Care Med (2017) 0.75
CT screening for lung cancer. Cleve Clin J Med (2007) 0.75
Arterial desaturation syndrome following pleurodesis with talc slurry: incidence, clinical features, and outcome. Cancer Invest (2003) 0.75
NCCN Roundtable:Value-Based Decision-Making at the Bedside. J Natl Compr Canc Netw (2015) 0.75